Intended for healthcare professionals


Drugs are as good as PCI in stable coronary artery disease, study shows

BMJ 2007; 334 doi: (Published 05 April 2007) Cite this as: BMJ 2007;334:713
  1. Susan Mayor
  1. London

    The risk of death, myocardial infarction, or other major cardiovascular events in patients with stable coronary artery disease is no lower with percutaneous coronary intervention (PCI) than with the optimal therapy of drug treatment with lifestyle intervention, says a major prospective study that is predicted to change practice.

    The trial, published online on 26 March in the New England Journal of Medicine (, doi: 10.1056/NEJMoa070829), randomised more than 2000 patients with objective evidence of myocardial ischaemia and significant coronary artery disease to PCI or optimal medical treatment. The results showed no difference in mortality from any cause or in the risk of non-fatal myocardial infarction at a median follow up of 4.6 years.

    The findings will change practice, said David Taggart, professor of cardiovascular surgery at Oxford University. …

    View Full Text

    Log in

    Log in through your institution


    * For online subscription